Wong 2008.
Study characteristics | |||
Patient Sampling | "All patients referred from different hospitals and clinics to the Joint Hepatoma Clinic of the Chinese University of Hong Kong, which is a tertiary centre for the management of suspected or confirmed liver tumours, between January 2003 and June 2005 were retrospectively studied. Nine hundred and eighty‐two patients visited the Joint Hepatoma Clinic during the study period. Five hundred and seventy‐nine patients were included in the analysis after excluding patients who had non viral hepatitis related disease (n = 168), had missed records (n = 79), had pre‐existing HCC (n = 30), had no USG (n = 119) and no AFP test (n = 7). Patients having chronic liver diseases caused by other aetiologies including alcoholic liver disease, autoimmune liver disease and primary biliary cirrhosis were excluded from the analysis." Age range: 46‐70. Males 83% |
||
Patient characteristics and setting | |||
Index tests | Patients with elevated AFP levels (defined as > 20 ng/mL) and/or with suspicious lesions (any space occupying lesion) on USG were referred to the Joint Hepatoma Clinic for further investigation. | ||
Target condition and reference standard(s) | All patients were assessed with same‐day US and AFP testing in the clinic within 2 weeks of referral. HCC was confirmed by histologic evidence of HCC from liver biopsy, typical appearance of tumour in a triphasic computerised tomography (CT) scan, characteristic lipoidal uptake in CT and/or neovascularisation and arterio‐venous shunting in hepatic arteriography. | ||
Flow and timing | No information on interval between index test and reference standard | ||
Comparative | |||
Notes | Conflict of interest: no conflicts of interest exist. | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | No | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | No | ||
Could the selection of patients have introduced bias? | High risk | ||
Are there concerns that the included patients and setting do not match the review question? | High | ||
DOMAIN 2: Index Test (AFP) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
If a threshold was used, was it pre‐specified? | Yes | ||
Could the conduct or interpretation of the index test have introduced bias? | Low risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
DOMAIN 2: Index Test (US+AFP) | |||
DOMAIN 2: Index Test (US) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
If a threshold was used, was it pre‐specified? | Yes | ||
Could the conduct or interpretation of the index test have introduced bias? | Low risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | No | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Yes | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | High risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | Low concern | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Unclear | ||
Did all patients receive the same reference standard? | No | ||
Were all patients included in the analysis? | Yes | ||
Could the patient flow have introduced bias? | High risk |